Crawled News Article
WASHINGTON: Air India's decision to start the first-ever nonstop flight between San Francisco and New Delhi has united two great cultural and economic centers of the world, San Francisco Mayor Ed Lee has said."I am pleased to welcome Air India to San Francisco - the Innovation Capital of the World - after the productive visit by India Prime Minister Narendra Modi to the San Francisco Bay Area," said San Francisco Mayor Ed Lee."By creating the first-ever nonstop service between San Francisco and Delhi, Air India has united two great cultural and economic centers of the world. As the only nonstop flight between India and the West Coast of the United States, I fully expect this new service to be a success," said Lee.Air India will begin the first-ever nonstop flights between San Francisco and Delhi on December 2, 2015.Air India plans to launch service with three flights per week, on Sunday, Wednesday, and Friday, using Boeing 777 long-range aircraft."I am excited that Air India has selected SFO for their newest route in the United States," said Airport Director John L Martin "This service firmly establishes our Airport as the premier gateway to Asia and the Subcontinent, and provides an unparalleled level of global access to our guests," he said.The new flight makes San Francisco the fourth American city served by Air India after Chicago New York and Newark.Flights between San Francisco and Delhi will be operated using Boeing 777-200LR aircraft seating a total of 238 passengers, made up of eight first class, 35 business class and 195 economy class seats.
Crawled News Article
The round was co-led by Bpifrance and Innovation Capital, with participation from Vesalius Biocapital, Qualcomm, through its venture capital arm, Qualcomm Ventures, and existing investors CapDecisif Management, CM-CIC Capital Innovation and Sham. The company intends to use the funds to accelerate the development of its diabetes management solution, advance new programs in other chronic diseases and ramp up its US operations. Founded in 2001 by Pierre Leurent, CEO, Voluntis develops proprietary companion software dedicated to managing chronic conditions such as diabetes, anticoagulation and hemophilia. In diabetes, its Voluntis Insulin Therapy Manager (VITM) is developed to support patients across the insulin pathway. The company, which also has offices in Boston, USA, also provides partners with development and regulatory capabilities to elaborate their own digital solution based upon its core system architecture.
Crawled News Article
U.K.-based healthcare appointment booking platform startup Zesty* has closed a $7.2 million Series A funding round to expand in the U.K. and into additional European markets. VC firm Innovation Capital led the round, with Qualcomm Ventures and Maya Capital also participating. Existing investors Mangrove Capital Partners, TA Venture and ABRT Fund also joined in. Zesty’s Series A follows an expanded seed intake of $2 million, in April 2014, after attracting initial (undisclosed) seed funding in January 2013, led by Mangrove Capital. The startup beta launched its booking platform in London back in May 2013, focusing on private and NHS dental services to test its business model. From there it expanded to include other healthcare verticals, such as private general practitioners; physiotherapy; osteopathy; chiropractic; podiatry; sports massage; facial cosmetics; and sexual health services — and to other U.K. cities. It’s currently live in 15+ towns and cities in the U.K., and says it’s aiming to step that up to all “main” U.K. towns and cities by the end of the year. It has 3,500+ healthcare professionals signed up to its booking platform in the U.K. as of now (up from 2,000+ in April 2014), and says it has 40,000 users booking appointments via Zesty each month. Its new funding will go towards accelerating growth in London, and for the aforementioned expansion across the U.K. It’s also targeting Western Europe — with a plan to launch in “major European cities” in the next 18 months. Zesty told TechCrunch its European markets of focus are: U.K., France, Germany, Italy, Spain, Holland, Sweden, Norway, Austria and Switzerland. Other startups playing in what is becoming an increasingly targeted space — unsurprisingly so, given the size of the opportunity to serve the healthcare needs of an on-demand generation — include the likes of U.S.-based ZocDoc and Poland’s DocPlanner. On the vertical side there’s also U.K.-based Toothpick (dentistry) and RightClinic (laser eye surgery and cosmetic treatments) to name two — with vertical specialists offering potential acquisition targets for any over-arching healthcare booking platform that can gain enough traction. Speaking to TechCrunch last year, Zesty co-founder Lloyd Price said the aim is to build a search engine for healthcare services, and one which will allow users to not only locate treatments by speciality but filter by highly granular preferences, such as languages spoken. Zesty’s booking platform integrates with existing healthcare providers’ practice management software using their APIs. But it also offers B2B tools to get an online booking system up and running for smaller practices — which might only be using the likes of Google Calendar or Outlook to manage appointments. Or even for those still using paper to manage appointments. As part of the new funding, Florian Reinaud, from Innovation Capital’s Paris office, will join Zesty’s Board, alongside David Waroquier from Mangrove Capital. Miles Kirby from Qualcomm Ventures also joins as a board observer. *Not to be confused with SF-based food delivery startup Zesty.
Crawled News Article
They were joined in the round by Qualcomm Ventures and Maya Capital, plus existing investors Mangrove Capital Partners, TA Ventures and ABRT. The London-based startup, which offers services including dental, GP and more specialist health bookings, will use the cash to expand in and outside of London, and grow its business across the rest of Europe. The company launched back in May 2013 and has more than 3,500 healthcare providers offering their services. As well as offering a one-stop-shop for people looking for appointments, clients can use Zesty’s APIs to integrate bookings into their existing infrastructure.
Crawled News Article
Zesty, a leading platform in the UK for consumer healthcare, today announced the successful completion of its $7.2 million Series A financing. As if we knew it: In January 2014 we introduced you to Zesty as one of 5 UK-based startups to look out for in 2014. The funding round was led by Innovation Capital and supported by Qualcomm Ventures, Mangrove Capital Partners and Maya Capital. Zesty, an online booking service allowing patients to book a healthcare appointment in less than 60 seconds, will use the funding to accelerate growth in London, across the UK and expansion into Europe. Co-founded by two technology entrepreneurs, James Balmain and Lloyd Price, the company received initial Seed money from Mangrove Capital Partners in 2012 followed by a second round of funding from Mangrove Capital, TA Venture and ABRT Venture Fund in 2013. James Balmain, CEO of Zesty, said: “Every day in major cities around the world, people waste millions of hours trying to book their healthcare appointments, and healthcare practices leave tens of millions of dollars on the table due to inefficiency in the market. Zesty has rapidly transformed from an exciting concept to a leading UK consumer healthcare platform, saving patients time and hassle. This round of investment will help us continue to enhance our already popular and revolutionary London network and to take our unique, hyper local strategy across the UK and Western Europe. Zesty will bring the elite London online booking experience to major European cities in the next 18 months.” Dr. Florian Reinaud, Partner at Innovation Capital, stated: “Through our new sector fund closed in 2014, we invest primarily in European-based companies providing innovative healthcare services or solutions. We believe mobile and internet based services will transform access to healthcare across Europe and Zesty is well positioned to be one of the leading brands connecting patients with practices. Over the past two years Zesty has demonstrated its ambition and execution capability by transforming a concept into the UK’s largest network of healthcare practices offering real time appointment booking. Our investment is a reflection of our confidence in the Zesty team and the massive opportunity ahead of them.”